Skip to content

Total Equity at other companies

Eli Lilly logo
Eli LillyLLY
$31.2B+97.9%
Amgen logo
AmgenAMGN
$9.19B+48.1%
Altimmune logo
AltimmuneALT
$283.99M+99.8%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$501.92M-40.7%
Wave Life Sciences logo
Wave Life SciencesWVE
$511.73M+198%
Prime Medicine logo
Prime MedicinePRME
$76.7M-28.3%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's total equity?
Vivani Medical (VANI) reported total equity of $19.09M in Q1 2026.
How has Vivani Medical's total equity changed year-over-year?
Vivani Medical's total equity increased by 64.2% year-over-year, from $11.62M to $19.09M.
What is the long-term trend for Vivani Medical's total equity?
Over 5 years (2020 to 2025), Vivani Medical's total equity has grown at a 51.8% compound annual growth rate (CAGR), from $1.95M to $15.73M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.